| Abbreviations | Meaning |
 | MPLV | Myeloproliferative Leukemia Virus |
| CLL | Chronic Lymphocytic Leukemia |
| PT | Pertussis Toxin; Postoperative Tumor Size [TNM (tumor-node-metastasis) Classification: PT0 Surgery Not Done Or Not Applicable, PT1 No Visible Tumor Tissue, PT2 Less Than 1.5 Cm Remains, PT3 1.5 To 5.0 Cm Remains, PT4 More Than 5.0 Cm Remains To Primary Tumors In Progressing Thickness, And PTX No Evidence Of Primary Tumor] |
| SSM | Superficial Spreading Melanoma |
| EATC | Ehrlich Ascites Tumor Cell |
| FL-M | Follicular Lymphoma Mixed Small Cleaved And Large |
| NABCO | National Alliance Of Breast Cancer Organizations |
| DS-TRIEL | Decision Support [cancer Clinical] Trial Eligibility |
| CMOL | Chronic Monocytic Leukemia |
| CCN | Cancer Center Network |
| NPCA | Nasopharyngeal Carcinoma |
| MTX | Methotrexate (anti Cancer Drug) |
| HHMMTV | Human Homologue Of Mouse Mammary Tumor Virus |
| SAS | Sarcoma Amplified Sequence |
| A | Tumor Limited To The Mucosa [Astler-Coller Classification] |
Browse by Letter:
